In vitro effects of new artemisinin derivatives in Neospora caninum-infected human fibroblasts

International Journal of Antimicrobial Agents

Volumn 46, Issue 1, 2015, Pages 88-93

  Müller, Joachim ^a   Balmer, Vreni ^a   Winzer, Pablo ^a   Rahman, Mahbubur ^a   Manser, Vera ^a   Haynes, Richard K ^b   Hemphill, Andrew ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b NORTH WEST UNIVERSITY   (South Africa)

Author keywords

Artemisinin; Artemisone; Chemotherapy; Neospora caninum; Resistance; Trioxolane

Indexed keywords

ARTEMISININ DERIVATIVE; ARTEMISONE; GC 007; GC 012; MESSENGER RNA; UNCLASSIFIED DRUG; ANTIPROTOZOAL AGENT; ARTEMISIN; LACTONE;

ARTICLE; BAG1 GENE; CELL PROLIFERATION; CELL VACUOLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG STRUCTURE; FIBROBLAST; GENE EXPRESSION; HUMAN; HUMAN CELL; IC50; IMMUNOFLUORESCENCE; IN VITRO STUDY; NEOSPORA CANINUM; NEOSPOROSIS; NONHUMAN; PARASITICIDAL ACTIVITY; PARASITOPHOROUS VACUOLE; PRIORITY JOURNAL; RNA GENE; SAG4 GENE; TACHYZOITE; TRANSMISSION ELECTRON MICROSCOPY; CELL CULTURE; CELL SURVIVAL; DRUG EFFECTS; DRUG REPOSITIONING; DRUG SENSITIVITY; DRUG TOLERANCE; NEOSPORA; PARASITOLOGY; ULTRASTRUCTURE;

ANTIPROTOZOAL AGENTS; ARTEMISININS; CELL SURVIVAL; CELLS, CULTURED; DRUG REPOSITIONING; DRUG TOLERANCE; FIBROBLASTS; HUMANS; INHIBITORY CONCENTRATION 50; LACTONES; MICROSCOPY, ELECTRON, TRANSMISSION; NEOSPORA; PARASITIC SENSITIVITY TESTS;

EID: 84935027733     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2015.02.020     Document Type: Article

References (15)

1. Monney T, Hemphill A. Vaccines against neosporosis: what can we learn from the past studies? Exp Parasitol 2014; 140:52-70.
2. Reichel MP, McAllister MM, Pomroy W.E., Campero C., Ortega-Mora LM, Ellis JT. Control options for Neospora caninum-is there anything new or are we going backwards? Parasitology 2014; 141:1455-70.
3. Paddon CJ, Keasling JD. Semi-synthetic artemisinin: a model for the use of synthetic biology in pharmaceutical development. Nat Rev Microbiol 2014; 12:355-67.
4. Haynes RK, Cheu KW, N'Da D, Coghi P, Monti D. Considerations on the mechanism of action of artemisinin antimalarials: Part 1-The 'carbon radical' and 'heme' hypotheses. Infect Disord Drug Targets 2013; 13:217-77.
5. Dunay IR, Chan WC, Haynes R.K., Sibley LD. Artemisone and artemiside control acute and reactivated toxoplasmosis in a murine model. Antimicrob Agents Chemother 2009; 53:4450-6.
6. D'Angelo JG, Bordon C, Posner G.H., Yolken R., Jones-Brando L. Artemisinin derivatives inhibit Toxoplasma gondii in vitro at multiple steps in the lytic cycle. J Antimicrob Chemother 2009; 63:146-50.
7. Lindsay DS, Dubey JP. Effects of sulfadiazine and amprolium on Neospora caninum (Protozoa: Apicomplexa) infections in mice. J Parasitol 1990; 76: 177-9.
8. Debache K, Hemphill A. Effects of miltefosine treatment in fibroblast cell cultures and in mice experimentally infected with Neospora caninum tachyzoites. Parasitology 2012; 139:934-44.
9. Schorer M, Debache K, Barna F., Monney T, Müller J, Boykin D.W., et al. Di-cationic arylimidamides act against Neospora caninum tachyzoites by interference in membrane structure and nucleolar integrity and are active against challenge infection in mice. Int J Parasitol Drugs Drug Resist 2012; 2:109-20.
10. Debache K, Guionaud C, Kropf C., Boykin D, Stephens CE, Hemphill A. Experimental treatment of Neospora caninum-infected mice with the arylimidamide DB750 and the thiazolide nitazoxanide. Exp Parasitol 2011; 129:95-100.
11. Mazuz ML, Haynes R, Shkap V., Fish L, Wollkomirsky R, Leibovich B., et al. Neospora caninum: in vivo and in vitro treatment with artemisone. Vet Parasitol 2012; 187:99-104.
12. Müller J, Hemphill A. Identification of a host cell target forthe thiazolide class of broad-spectrum anti-parasitic drugs. Exp Parasitol 2011; 128:145-50.
13. Vonlaufen N, Müller N, Keller N., Naguleswaran A, Bohne W, McAllister M.M., et al. Exogenous nitric oxide triggers Neospora caninum tachyzoite-to-bradyzoite stage conversion in murine epidermal keratinocyte cell cultures. Int J Parasitol 2002; 32:1253-65.
14. Kim JT, Park JY, Seo H.S., Oh HG, Noh JW, Kim JH, et al. In vitro antiprotozoal effects of artemisinin on Neospora caninum. Vet Parasitol 2002; 103: 53-63.
15. Haynes RK. From artemisinin to new artemisinin antimalarials: biosynthesis, extraction, old and new derivatives, stereochemistry and medicinal chemistry requirements. CurrTop Med Chem 2006; 6:509-37.